BR112016030368A2
(en)
|
|
ophthalmic composition
|
DK3089741T3
(en)
|
|
PHARMACEUTICAL COMPOSITIONS INCLUDING AZD9291
|
BR112016023628A2
(en)
|
|
pharmaceutical compositions.
|
DK3229810T3
(en)
|
|
PHOSPHOLIPID-ETHER ANALOGES AS CANCER-DISABLING MEDICINES
|
BR112016026879A2
(en)
|
|
LIQUID PHARMACEUTICAL COMPOSITION
|
DK3542812T3
(en)
|
|
GLYCOPEPTIME COMPOSITIONS
|
DK3040326T3
(en)
|
|
HALOOLEFIN-BASED COMPOSITION
|
GB201409471D0
(en)
|
|
Pharmaceutical composition
|
FR3024363B1
(en)
|
|
THERMOGELIFIABLE COMPOSITION
|
DK3231803T3
(en)
|
|
DIHYDROINDOLIZINON DERIVATIVES
|
CL2015001019S1
(en)
|
|
Vial
|
DK3199161T3
(en)
|
|
Pharmaceutical preparation
|
GB201409485D0
(en)
|
|
Pharmaceutical composition
|
GB201409488D0
(en)
|
|
Pharmaceutical composition
|
DK3145488T3
(en)
|
|
LIQUID PHARMACEUTICAL COMPOUND
|
DK3131898T3
(en)
|
|
Fluoroalkylfluorene derivatives
|
CL2017000639A1
(en)
|
|
Composition
|
DK3191466T3
(en)
|
|
AZETIDINYLOXYPHENYLPYRROLIDINE COMPOUNDS
|
DK3191085T3
(en)
|
|
ABUSE-RESISTANT PHARMACEUTICAL COMPOSITIONS
|
DK3200827T3
(en)
|
|
COMPOSITIONS
|
DK3217964T3
(en)
|
|
COMPOSITION
|
DK3148513T3
(en)
|
|
Ceritinib formulation
|
FR3019552B1
(en)
|
|
FILMOGENE COMPOSITION
|
DK3288967T3
(en)
|
|
PHARMACEUTICAL RELATIONSHIP
|
DK3089740T3
(en)
|
|
PHARMACEUTICAL COMPOSITION
|